These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7985487)

  • 41. [Subcutaneous calcifications: a rare side effect of calcium heparin].
    Tumiati B; Azzarito C; lo Scocco G; Veneziani M; Bertani A
    Medicina (Firenze); 1988; 8(3):322-3. PubMed ID: 3231046
    [No Abstract]   [Full Text] [Related]  

  • 42. [Frequency of severe abdominal wall hemorrhage with subcutaneous anticoagulation using calcium-heparin].
    Brugger HP; Pirovino M
    Schweiz Med Wochenschr; 1989 Jan; 119(1):16-8. PubMed ID: 2521748
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Heparins, antivitamins K. Principles and rules of use. Posology of non-fractionated heparins].
    Delsart D; Chambefort V; Decousus H
    Rev Prat; 2001 Sep; 51(13):1489-97. PubMed ID: 11601082
    [No Abstract]   [Full Text] [Related]  

  • 44. Thrombin and platelet inhibition with low-dose calcium-heparin in comparison with ASA in patients with peripheral arterial occlusive disease at Leriche-Fontaine IIb class.
    Allegra C; Pollari G; Carioti B; Sardina M
    Int J Clin Pharmacol Ther; 1994 Dec; 32(12):646-51. PubMed ID: 7881702
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Danger of treatment protocols.
    Cucchiara B; Messé S; Kasner SE
    Stroke; 2003 May; 34(5):e19. PubMed ID: 12690208
    [No Abstract]   [Full Text] [Related]  

  • 46. [Successful delivery following subcutaneous heparin administration in a 7-weeks pregnant patient suffering from cerebral venous thrombosis due to secondary protein S deficiency].
    Nozaki H; Naruse S; Koike T; Okuizumi Y; Fujita N; Nagai H
    Rinsho Shinkeigaku; 2006 Mar; 46(3):233-5. PubMed ID: 16642938
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Low-molecular-weight heparin: prophylaxis and treatment of venous thromboembolism.
    Pineo GF; Hull RD
    Annu Rev Med; 1997; 48():79-91. PubMed ID: 9046947
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Hypereosinophilia after calcium heparinate].
    Mouton Schleifer D; Chassaing S; Caron F; Borg JY; Bouchart F; Soyer R
    Presse Med; 1996 Nov; 25(37):1848. PubMed ID: 8991043
    [No Abstract]   [Full Text] [Related]  

  • 49. Olanzapine-induced triglyceride and aminotransferase elevations without weight gain or hyperglycemia normalized after switching to aripiprazole.
    Pawelczyk T; Pawelczyk A; Rabe-Jablonska J
    J Psychiatr Pract; 2014 Jul; 20(4):301-7. PubMed ID: 25036587
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preoperative stop or continue? New antithrombotic and anticoagulants.
    Ickx BE
    Acta Anaesthesiol Belg; 2001; 52(4):385-93. PubMed ID: 11799571
    [No Abstract]   [Full Text] [Related]  

  • 51. Comparative plasma heparin levels after subcutaneous sodium and calcium heparin.
    Low J; Biggs JC
    Thromb Haemost; 1978 Oct; 40(2):397-406. PubMed ID: 734636
    [No Abstract]   [Full Text] [Related]  

  • 52. [Skin necrosis related to subcutaneous heparin administration. Heparin necrosis].
    Berkessy S; Tuka P; Radványi G; Balyi G; Pauker Z; Somogyi E; Takács I
    Orv Hetil; 1981 Dec; 122(50):3075-80. PubMed ID: 7329684
    [No Abstract]   [Full Text] [Related]  

  • 53. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism.
    Büller HR; Davidson BL; Decousus H; Gallus A; Gent M; Piovella F; Prins MH; Raskob G; van den Berg-Segers AE; Cariou R; Leeuwenkamp O; Lensing AW;
    N Engl J Med; 2003 Oct; 349(18):1695-702. PubMed ID: 14585937
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Eosinophilic panniculitis after subcutaneous administration of sodium heparin.
    Batalla A; Rosón E; Posada C; Flórez A
    Indian J Dermatol Venereol Leprol; 2013; 79(6):849. PubMed ID: 24177633
    [No Abstract]   [Full Text] [Related]  

  • 55. [Postoperative use of elastic stockings to prevent thrombosis: what is most effective].
    Meyer G
    Pflege Z; 2004 Apr; 57(4):249-52. PubMed ID: 15141493
    [No Abstract]   [Full Text] [Related]  

  • 56. Bivalirudin for prevention of prosthetic valve thrombosis in heparin allergy.
    Palacios-Rubio J; Cano L; Vilacosta I; Vivas D
    J Card Surg; 2013 Sep; 28(5):520-1. PubMed ID: 23909407
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Low dose heparin therapy. A study of the local effects of 5,000 international units of sodium heparin and calcium heparin].
    Arendrup H; Toftgaard C
    Ugeskr Laeger; 1979 Apr; 141(18):1203-6. PubMed ID: 375523
    [No Abstract]   [Full Text] [Related]  

  • 58. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
    Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM
    JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Advances in therapy and prevention of ischemic myocardial infarct].
    Mattle HP
    Schweiz Med Wochenschr; 1997 Oct; 127(40):1663-6. PubMed ID: 9417588
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of a combination of antiplatelet and antithrombotic pretreatment on myocardial perfusion in patients with an acute ST-segment elevation myocardial infarction undergoing a primary percutaneous coronary intervention.
    Prech M; Bartela E; Janus M; Jeremicz I; Araszkiewicz A; Urbanska L; Pyda M; Grajek S
    Coron Artery Dis; 2016 Nov; 27(7):580-5. PubMed ID: 27228184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.